Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2000
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2354189A1 Methods of inhibiting ectopic calcification
06/15/2000CA2354022A1 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000CA2354021A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/15/2000CA2350888A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
06/15/2000CA2350590A1 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/14/2000EP1007650A1 Pca3, pca3 genes, and methods of use
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007084A1 Immunogenic lhrh compositions and methods relating thereto
06/14/2000EP1007080A1 Sustained peptide-release formulation
06/14/2000EP1007071A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007023A1 Medical treatment
06/14/2000EP1007010A2 Pharmaceutical composition comprising an azasteroid
06/14/2000EP0820426B1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION
06/14/2000CN1256132A Medicine for enuresis and its preparation
06/14/2000CN1053368C Pill for treatment of nephritis
06/13/2000US6075136 Polynucleotide sequence coding a polypeptide with enzymatic activity; for treating or preventing cancer and reproductive defects; anticarciongenic agents
06/13/2000US6075054 Antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment as well as for the treatment of angina pectoris
06/13/2000US6075037 Endothelin receptor antagonists
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032218A1 Controlled release formulation comprising gnrh-ii
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032182A1 The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
06/08/2000WO2000016760A3 New use of prostaglandin e2 antagonists
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000012481A3 Indazole derivatives with 5-ht2 receptor activity________________
06/08/2000WO2000007629A3 Peg-urate oxidase conjugates and use thereof
06/08/2000CA2353798A1 Controlled release formulation comprising gnrh-ii
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352199A1 The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005346A2 Solutions containing azasteroids
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds
06/07/2000CN1255332A Release-controlled micropill for treating benign prostatic hyperplasis and its preparing process
06/07/2000CN1053114C Medicine for curing bilestone and biliary calculus
06/07/2000CN1053112C Medicine for treating nephropathy and gastropathy
06/06/2000US6071938 Benzopyrans
06/06/2000US6071931 AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
06/06/2000US6071920 Bind to 5ht 1a receptors for treating disorders of the lower urinary tract; cns disorders; anxiolytic agents; antidepressants; hypotensive agents; sleep and eating disorders
06/06/2000US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis
06/06/2000US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071882 Administering an effective synergistic amount of leuteinizing hormone releasing hormone antagonist cetrorelix in combination with alpha-receptor blocking agents to treat the prostate hypertrophy and prostate cancer
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031070A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031060A1 Scavenger compounds
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031047A1 Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceuticalreparations containing same
06/02/2000WO2000031046A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
06/02/2000WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000013703A9 Methods of treating hypertension and compositions for use therein
06/02/2000WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
06/02/2000WO1999061097A9 Alpha emitting constructs and uses thereof
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352144A1 Scavenger compounds
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
06/02/2000CA2351361A1 Gtpase associated proteins
05/2000
05/31/2000EP1004598A2 Coated carrier materials for the purification of blood, plasma and tissues, and columns comprising said carrier materials
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003744A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
05/31/2000EP1003740A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists
05/31/2000EP1003734A2 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003713A1 Anthranilic acid analogs
05/31/2000EP1003712A1 Anthranilic acid analogs
05/31/2000EP1003557A2 New salts with beneficial organoleptic properties
05/31/2000EP1003544A1 C1q AND COLLECTIN RECEPTOR
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003512A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
05/31/2000EP1003511A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS
05/31/2000EP1003509A1 Il-8 receptor antagonists
05/31/2000EP1003505A1 Heterocyclic vinylethers against neurological disorders
05/31/2000EP1003504A2 Indole derivatives and their use as mcp-1 antagonists
05/31/2000EP1003497A1 Il-8 receptor antagonists
05/31/2000EP1003496A1 Method for chemoprevention of prostate cancer
05/31/2000EP1003479A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases
05/31/2000EP1003374A4 Inhibitors of farnesyl-protein transferase
05/31/2000EP1003374A1 Inhibitors of farnesyl-protein transferase
05/31/2000EP0865428B1 Vitamin d analogues
1 ... 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 ... 562